🔥 Aspirin prevents colorectal cancer and cancer metastasis - explanation of the mechanistic effects Source: NEJM x.com/erictopol/stat…

Out Now! IL-17-mediated antifungal immunity restricts Candida albicans pathogenicity in the oral cavity bit.ly/499rOM4 #IL17 #CandidaAlbicans #FungalImmunity

Interesting

✅ Editor’s Choice: This Review summarizes the epidemiology, clinical presentation, pathophysiology, and management of renal cell #carcinoma (RCC). In 2023, there were an estimated 81 800 newly diagnosed cases of RCC in the US. 💾 Save this Review for your citations:

Research Methodology and Scientific Writing Publisher Springer (2021) النسخه الثانيه المجانيه لطرق الكتابه والمنهجيه البحثيه👇🏼 download.e-bookshelf.de/download/0015/…

Anyone working on their SOP and need help? linkedin.com/posts/afairsho…

Important that diagnosis and screening is still very low in Africa and setting the pace for precision medicine which is much needed.

Applications for our Master of Science in Global Health Delivery #MGHD, are still open. Now with 5 options available. Deadline: Jan 18, 2026, 5 PM CAT #ApplytoUGHE: go.ughe.org/mghd_admissions

Extracellular vesicles (EVs) aren't just cellular debris. They influence viral transmission, immune modulation, and disease outcomes. This #mBio review summarizes current insights into EV biogenesis, cargo, and their dual role in infection & pathogenesis. doi.org/10.1128/mbio.0…

Targeting γδ T cells for immunotherapies against colorectal cancer dlvr.it/TPwj75 #immunology

Celebrating 10 Years of AfriBoP courses. Trained more than 500 #African scientists. The 2026 course will be hosted by Stellenbosch University

Our researchers, Prof. Isabella Oyier, Head of Bioscience, KEMRI-Wellcome and Prof. Abdirahman Abdi, Senior Researcher, KEMRI-Wellcome presenting during the symposium on multi-pathogen genomic surveillance in the ongoing #KASHConference.

Day 3 of the ongoing #KASHConference kicks off with a plenary session from Prof. Isabella Oyier, Head of Bioscience, KEMRI-Wellcome on “Molecular Innovations for Health Facility-based Surveillance of Antimalaria Drug Resistance.”

James Kimani, a Master’s Fellow, presented at #KASH2026 on the population structure of Plasmodium falciparum in Kilifi. His research reveals local parasite substructures and underscores the need to tailor malaria interventions to specific regions rather than apply them uniformly.

Emmanuel Asiimwe, a Master’s Fellow, presents his research at the #KASH2026 conference. His work examines how Plasmodium falciparum persists and adapts despite decades of malaria control and intervention.

Prof Faith Osier: The Kenyan scientist bringing vaccine manufacturing closer home #HealthyNation zurl.co/2Ay0e

Go Fridah 😊 So proud of you ♥️

Commonwealth Distance Learning Master’s #Scholarships 2026/2027 for developing Commonwealth countries (Fully Funded) CSC in the UK tinyurl.com/4ntet4vm

📣 Calling all past AFRIBOP students. Please DM me your quotes on the importance of the course for you. Also provide an update on where you are with your careers now ? IDeAL, Africa #AFRIBOP2026

🚨 Call for Applications: ViGOR Research Fellowships Are you an early-career researcher in Africa ready to drive impact in public health? Apply for the ViGOR Fellowships in Virus Genomics or Outbreak Modelling. Gain access to expert mentorship, hands-on training, and up to